Cleveland Clinic Achieves Global Healthcare Accreditation for a Second Term

Cleveland Clinic has been awarded “Accreditation with Excellence” for its medical travel services by Global Healthcare Accreditation (GHA) for a second consecutive term.

Cleveland Clinic – now in its centennial year – is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.

GHA has developed international standards (accredited by ISQUA) and professional norms for medical travel – also known as medical tourism and health tourism – in consultation with leading global experts in the industries it represents, including health providers, insurers, and employers. The GHA accreditation seal helps build trust by demonstrating to patients and international payers that the organization has implemented procedures and policies designed to mitigate risks to medical travel patients and enhance the patient experience across each step of the patient journey.

“This accreditation is a testament to Cleveland Clinic’s focus on patient experience,” said Maan Fares, M.D., interim chair of Global Patient Services at Cleveland Clinic.  “It is recognition of our commitment to providing quality care to patients around the world.”

Cleveland Clinic was officially notified of its renewed accreditation status on June 4, 2021, after completing a three-day remote accreditation survey conducted by two GHA surveyors.

Karen Timmons, GHA’s Chief Executive Officer said, “Global Healthcare Accreditation provides a unique opportunity for organizations to conduct a deep dive into their global/international patient service units and an opportunity to have an impact on improving the quality, safety and experience for all patients who travel for care.  GHA provides the ideal starting point to validate current processes while focusing specifically on operational excellence and the patient experience, a business strategy that will impact organizations across all services provided. We congratulate Cleveland Clinic, and its dedicated caregivers on achieving GHA Accreditation with Excellence, and for the organization’s unwavering focus on service excellence and commitment to supporting the unique needs of medical travel patients.”

According to Sandy Milli, senior director of Global Patient Services at Cleveland Clinic, “We are delighted to have received the Global Healthcare Accreditation, this demonstrates our commitment to providing the highest quality care to our patients when they are traveling abroad for their medical care. This accreditation is a testament to our entire organization’s dedication to patient care.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”